Vaccine News and Research

Latest Vaccine News and Research

Effect of prior SARS-CoV-2 infection on post-vaccination SARS-CoV-2 spike IgG antibodies

Natural infection or vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confer considerable protection against reinfection and reduce the risk of severe Coronavirus disease 2019 (COVID-19) outcomes.

24 Sep 2021

Mathematical constructions of SARS-CoV-2 action could help fine-tune prevention and treatment

Mathematical constructions of the action of SARS-CoV-2 and its multiple spikes, which enable its success at infecting cells, can give vaccine developers and pharmaceutical companies alike a more precise picture of what the virus is doing inside us and help fine tune prevention and treatment, mathematical modelers say.

23 Sep 2021

Potential covalent SARS-CoV-2 spike protein inhibitors

There remains a significant need for new and effective drugs that can be used to treat COVID-19.

23 Sep 2021

COVID-19 vaccination and lactation

A new study evaluates the presence of antibodies in breastmilk and the immune responses of lactating women after vaccination of the COVID-19 vaccine.

23 Sep 2021

Design of mRNA vaccines to combat COVID-19

A recent review study discusses fundamental concepts in the successful delivery of nucleic acids in therapeutics.

23 Sep 2021

COVID-19 vaccination eases healthcare demand

A new study discusses a model that has been developed to predict the effects of relaxing restrictions on the number of new COVID-19 cases.

23 Sep 2021

New web portal launched to help people address myths about Covid-19 vaccines

How do you have a constructive conversation with someone who doesn't want to or is reluctant to be vaccinated against Covid-19? A new web portal has been launched in Sweden to help ordinary people address myths and misconceptions about the vaccines, using evidence-based advice and support.

23 Sep 2021

KHN’s ‘What the Health?’: The autumn of Democrats’ discontent

Democrats in Congress and the White House are feverishly negotiating to pass as much of President Joe Biden's domestic agenda as they can agree on, even as Republicans who oppose much of the increased spending threaten to shut down the government and default on the nation's debt.

23 Sep 2021

People with natural immunity and subsequent mRNA vaccination can neutralize viral particles capable of resisting vaccine-induced antibodies

New research suggests SARS-CoV-2 spike protein substitution mutations can create a replication-defective viral particle that makes the virus resistant to vaccine-induced antibodies.

23 Sep 2021

Substantial differences in vaccination rates among immigrant health care workers in Norway

A new preprint examined the COVID-19 vaccination rates among HCWs in Norway, according to immigrant background.

23 Sep 2021

Varying immune responses after single dose of Pfizer and AstraZeneca COVID-19 vaccines

A new preprint describes the significant variation in the early immune response elicited by two of the earliest vaccines to gain emergency authorization against COVID-19.

23 Sep 2021

The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy

In a paper, the vaccine-induced cellular and immune response of MS patients receiving a range of therapies are assessed.

23 Sep 2021

Antibody kinetics in recovered COVID-19 patients

Researchers from Tel Aviv University have been examining the kinetics of antibodies in recovered COVID-19 patients.

23 Sep 2021

McLean wins NIH grant to explore links between COVID-19 vaccine and menstrual cycle changes

In research that will add important data to the experience of vaccines on women's health, Laura Payne, PhD, director of McLean Hospital's Clinical and Translational Pain Research Laboratory, has received a grant from the National Institutes of Health to explore potential links between SARS-CoV-2 vaccination and menstrual cycle changes.

23 Sep 2021

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Researchers have warned that the United States has not yet reached the necessary thresholds for achieving population immunity against severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

22 Sep 2021

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Researchers in Canada, Italy, and the United States have encouraged extending the interval time between two doses of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine among individuals who have not previously been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

22 Sep 2021

Bluetooth-based contact-tracing apps could enhance vaccine strategies

Mathematical modeling of disease spread suggests that herd immunity could be achieved with fewer vaccine doses by using Bluetooth-based contact-tracing apps to identify people who have more exposure to others - and targeting them for vaccination.

22 Sep 2021

Pregnant women who receive COVID-19 vaccine pass high levels of antibodies to their babies

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, a new study finds.

22 Sep 2021

COVID-19 will become a seasonal disease, U-M epidemiologist says

A University of Michigan epidemiologist believes that COVID-19 will become a seasonal disease, likely in the fall and winter seasons.

22 Sep 2021

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

Scientists from the USA have recently compared the dynamics of humoral and cellular immune responses induced by mRNA-based and adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. The findings reveal a difference in humoral immune responses. The study is currently available on the medRxiv* preprint server.

22 Sep 2021

Vaccine News and Research

Latest Vaccine News and Research

Effect of prior SARS-CoV-2 infection on post-vaccination SARS-CoV-2 spike IgG antibodies

Mathematical constructions of SARS-CoV-2 action could help fine-tune prevention and treatment

Potential covalent SARS-CoV-2 spike protein inhibitors

COVID-19 vaccination and lactation

Design of mRNA vaccines to combat COVID-19

COVID-19 vaccination eases healthcare demand

New web portal launched to help people address myths about Covid-19 vaccines

KHN’s ‘What the Health?’: The autumn of Democrats’ discontent

People with natural immunity and subsequent mRNA vaccination can neutralize viral particles capable of resisting vaccine-induced antibodies

Substantial differences in vaccination rates among immigrant health care workers in Norway

Varying immune responses after single dose of Pfizer and AstraZeneca COVID-19 vaccines

The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy

Antibody kinetics in recovered COVID-19 patients

McLean wins NIH grant to explore links between COVID-19 vaccine and menstrual cycle changes

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Bluetooth-based contact-tracing apps could enhance vaccine strategies

Pregnant women who receive COVID-19 vaccine pass high levels of antibodies to their babies

COVID-19 will become a seasonal disease, U-M epidemiologist says

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in